Cancer-on-a-chip systems at the frontier of nanomedicine

Drug Discovery Today

Volumn 22, Issue 9, 2017, Pages 1392-1399

  Zhang, Yu Shrike ^a   Zhang, Yi Nan ^b   Zhang, Weijia ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MODEL; CANCER ON A CHIP; CLINICAL EFFECTIVENESS; HUMAN; IN VITRO STUDY; LAB ON A CHIP; MALIGNANT NEOPLASM; MICROFLUIDICS; NANOMEDICINE; NONHUMAN; REVIEW; TISSUE ENGINEERING; TUMOR MICROENVIRONMENT; ANIMAL; BIOLOGICAL MODEL; NEOPLASM;

BIOMIMETIC MATERIAL;

ANIMALS; BIOMIMETIC MATERIALS; HUMANS; MODELS, BIOLOGICAL; NANOMEDICINE; NEOPLASMS;

EID: 85017474227     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2017.03.011     Document Type: Review

References (73)

1. Sun, T., et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. 53 (2014), 12320–12364.
2. Xia, Y., Nanomaterials at work in biomedical research. Nat. Mater. 7 (2008), 758–760.
3. Farokhzad, O.C., Langer, R., Impact of nanotechnology on drug delivery. ACS Nano 3 (2009), 16–20.
4. Jang, H.L., et al. Boosting clinical translation of nanomedicine. Nanomedicine 11 (2016), 1495–1497.
5. Wilhelm, S., et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater., 1, 2016, 16014.
6. McGonigle, P., Ruggeri, B., Animal models of human disease: challenges in enabling translation. Biochem. Pharmacol. 87 (2014), 162–171.
7. Bhise, N.S., et al. Organ-on-a-chip platforms for studying drug delivery systems. J. Control. Release 190 (2014), 82–93.
8. Zhang, Y.S., Khademhosseini, A., Seeking the right context for evaluating nanomedicine: from tissue models in petri dishes to microfluidic organs-on-a-chip. Nanomedicine 10 (2015), 685–688.
9. Maschmeyer, I., et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip 15 (2015), 2688–2699.
10. Esch, M., et al. The role of body-on-a-chip devices in drug and toxicity studies. Ann. Rev. Biomed. Eng. 13 (2011), 55–72.
11. Sung, J.H., et al. Using physiologically-based pharmacokinetic-guided ‘body-on-a-chip’ systems to predict mammalian response to drug and chemical exposure. Exp. Biol. Med. 239 (2014), 1225–1239.
12. Esch, E.W., et al. Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug Discov. 14 (2015), 248–260.
13. Bhatia, S.N., Ingber, D.E., Microfluidic organs-on-chips. Nat. Biotech. 32 (2014), 760–772.
14. Ingber, D.E., Reverse engineering human pathophysiology with organs-on-chips. Cell 164 (2016), 1105–1109.
15. Park, J., et al. Microfluidic compartmentalized co-culture platform for CNS axon myelination research. Biomed. Microdevices 11 (2009), 1145–1153.
16. Grosberg, A., et al. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 11 (2011), 4165–4173.
17. Agarwal, A., et al. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 13 (2013), 3599–3608.
18. Zhang, Y.S., et al. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials 110 (2016), 45–59.
19. Huh, D., et al. Reconstituting organ-level lung functions on a chip. Science 328 (2010), 1662–1668.
20. Huh, D., et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc. Natl. Acad. Sci. 104 (2007), 18886–18891.
21. Douville, N.J., et al. Combination of fluid and solid mechanical stresses contribute to cell death and detachment in a microfluidic alveolar model. Lab Chip 11 (2011), 609–619.
22. Kane, B.J., et al. Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal. Chem. 78 (2006), 4291–4298.
23. Carraro, A., et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed. Microdevices 10 (2008), 795–805.
24. Bhise, N.S., et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication, 8, 2016, 014101.
25. Lee, P.J., et al. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol. Bioeng. 97 (2007), 1340–1346.
26. Imura, Y., et al. A microfluidic system to evaluate intestinal absorption. Analyt. Sci. 25 (2009), 1403–1407.
27. Kimura, H., et al. An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. Lab Chip 8 (2008), 741–746.
28. Kim, H.J., et al. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12 (2012), 2165–2174.
29. Kim, H.J., et al. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc. Natl. Acad. Sci. 113 (2016), E7–15.
30. Zhang, W., et al. Elastomeric free-form blood vessels for interconnecting organs on chip systems. Lab Chip 16 (2016), 1579–1586.
31. Ribas, J., et al. Cardiovascular organ-on-a-chip platforms for drug discovery and development. Appl. in vitro Toxicol. 2 (2016), 82–96.
32. Yasotharan, S., et al. Artery-on-a-chip platform for automated, multimodal assessment of cerebral blood vessel structure and function. Lab Chip 15 (2015), 2660–2669.
33. Jang, K.-J., et al. Fluid-shear-stress-induced translocation of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells. Integr. Biol. 3 (2011), 134–141.
34. Jang, K.-J., Suh, K.-Y., A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 10 (2010), 36–42.
35. Nesmith, A.P., et al. Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. Lab Chip 14 (2014), 3925–3936.
36. Lee, J.-H., et al. Microfluidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials. Biomaterials 33 (2012), 999–1006.
37. Moraes, C., et al. Organs-on-a-chip: a focus on compartmentalized microdevices. Ann. Biomed. Eng. 40 (2012), 1211–1227.
38. Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9 (2009), 239–252.
39. Turley, S.J., et al. Immunological hallmarks of stromal cells in the tumour microenvironment. Nat. Rev. Immunol. 15 (2015), 669–682.
40. Wlodkowic, D., Cooper, J.M., Tumors on chips: oncology meets microfluidics. Curr. Opin. Chem. Biol. 14 (2010), 556–567.
41. Young, E.W.K., Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. Integr. Biol. 5 (2013), 1096–1109.
42. Vidi, P.-A., et al. Disease-on-a-chip: mimicry of tumor growth in mammary ducts. Lab Chip 14 (2014), 172–177.
43. Tanner, K., Gottesman, M.M., Beyond 3D culture models of cancer. Sci. Transl. Med., 7, 2015, 283ps9.
44. Carvalho, M.R., et al. Evaluating biomaterial- and microfluidic-based 3D tumor models. Trends Biotechnol. 33 (2015), 667–678.
45. Choi, Y., et al. A microengineered pathophysiological model of early-stage breast cancer. Lab Chip 15 (2015), 3350–3357.
46. Gioiella, F., et al. An engineered breast cancer model on a chip to replicate ECM-activation in vitro during tumor progression. Adv. Healthcare Mater. 5 (2016), 3074–3084.
47. Aung, A., et al. Chemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform. Lab Chip 16 (2016), 1886–1898.
48. Astolfi, M., et al. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy. Lab Chip 16 (2016), 312–325.
49. Ruppen, J., et al. A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids. Lab Chip 14 (2014), 1198–1205.
50. Ruppen, J., et al. Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform. Lab Chip 15 (2015), 3076–3085.
51. Yu, T., et al. Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device. Oncotarget 7 (2016), 25593–25603.
52. Fan, Y., et al. Engineering a brain cancer chip for high-throughput drug screening. Sci. Rep., 6, 2016, 25062.
53. Liu, P.-F., et al. A bladder cancer microenvironment simulation system based on a microfluidic co-culture model. Oncotarget 6 (2015), 37695–37705.
54. Zheng, Y., et al. Angiogenesis in liquid tumors: an in vitro assay for leukemic cell induced bone marrow angiogenesis. Adv. Healthcare Mater. 5 (2016), 1014–1024.
55. Pak, C., et al. MicroC3: an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Integr. Biol. 7 (2015), 643–654.
56. Farokhzad, O.C., et al. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Analyt. Chem. 77 (2005), 5453–5459.
57. Lee, J., et al. In vitro toxicity testing of nanoparticles in 3D cell culture. Small 5 (2009), 1213–1221.
58. Grafton, M.M.G., et al. Breast on-a-chip: mimicry of the channeling system of the breast for development of theranostics. Integr. Biol. 3 (2011), 451–459.
59. Yang, Y., et al. Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model. Lab Chip 15 (2015), 735–744.
60. Prabhakarpandian, B., et al. Synthetic tumor networks for screening drug delivery systems. J. Control. Release 201 (2015), 49–55.
61. Albanese, A., et al. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nat. Commun., 4, 2013, 2718.
62. Zervantonakis, I.K., Arvanitis, C.D., Controlled drug release and chemotherapy response in a novel acoustofluidic 3D tumor platform. Small 12 (2016), 2616–2626.
63. FDA_Voice, FDA Voice Interviews Jesse Goodman, M.D., M.P.H., on the DARPA and NIH Project Collaboration: Human on a Chip. 2012, FDA.
64. Skardal, A., et al. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. Drug Discov. Today 21 (2016), 1399–1411.
65. Danquah, M.K., et al. Extravasation of polymeric nanomedicines across tumor vasculature. Adv. Drug Deliv. Rev. 63 (2011), 623–639.
66. Jain, R.K., Stylianopoulos, T., Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7 (2010), 653–664.
67. Zhang, Y.-N., et al. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J. Control. Release 240 (2016), 332–348.
68. Hirai, T., et al. Metal nanoparticles in the presence of lipopolysaccharides trigger the onset of metal allergy in mice. Nat. Nanotechnol. 11 (2016), 808–816.
69. Huh, D., et al. Microengineered physiological biomimicry: organs-on-chips. Lab Chip 12 (2012), 2156–2164.
70. Zhang, C., et al. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 9 (2009), 3185–3192.
71. Wikswo, J.P., et al. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip 13 (2013), 3496–3511.
72. Chen, Y.Y., et al. Clarifying intact 3D tissues on a microfluidic chip for high-throughput structural analysis. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 14915–14920.
73. Zhang, Y.S., Yu, C., Towards engineering integrated cardiac organoids: beating recorded. J. Thoracic Dis. 8 (2016), E1683–E1687.